Heaps of posters seem to share your sentiment.
I've watched a few ASX listed biotechs duel list on the NASDAQ and if anything they started to get pummeled even worse.
And a couple of NASDAQ only listed biotechs I follow have share prices a tiny fraction of what they were a year or two ago.
Even the US biotech ETFs seem to underperform the main indices.
- Forums
- ASX - By Stock
- RAD
- News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN, page-19
Featured News
Add RAD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $58.66M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.7¢ | $274.3K | 10.02M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 416231 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 888375 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 416231 | 0.026 |
4 | 1550000 | 0.025 |
5 | 1358333 | 0.024 |
8 | 859004 | 0.023 |
5 | 3545454 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 888375 | 4 |
0.029 | 427208 | 4 |
0.030 | 756342 | 3 |
0.031 | 509676 | 3 |
0.032 | 400000 | 1 |
Last trade - 15.54pm 19/11/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |